Caroline Baumal, Chief Medical Officer: Apellis Pharmaceuticals APLS Sell · Filed 01/23

Trade details

Type: Insider sale
Amount: $60,890.69
Shares · price: 2,797 sh · $21.77 a share
Held after: 86,527 sh
Stock: Apellis Pharmaceuticals APLS
Person: Caroline BaumalChief Medical Officer
Trade date: 26/01/22
Filed: 26/01/23
Days to filing: 1 days

Sold 3.1% of holdings

Share of holding sold: 3.1%

Apellis Pharmaceuticals trades, last 26 weeks

What else happened in Apellis Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/12/23~02/21

Caroline Baumal's recent trades

Caroline BaumalChief Medical Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$37.2K
1,882 sh
$37.2K
Filed 01/21
Traded 01/20
Caroline BaumalChief Medical Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$77.1K
3,020 sh
$77.1K
Filed 01/06
Traded 01/05
Caroline BaumalChief Medical Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$55.5K
1,853 sh
$55.5K
Filed 25/01/21
Traded 25/01/17
Caroline BaumalChief Medical Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$95.2K
2,816 sh
$95.2K
Filed 25/01/08
Traded 25/01/06
Caroline BaumalChief Medical Officer
SellApellis Pharmaceuticals
Sell
Apellis Pharmaceuticals
APLS
$165.2K
2,751 sh
$165.2K
Filed 24/01/05
Traded 24/01/04